{"id":"red-blood-cell-transfusion","safety":{"commonSideEffects":[{"rate":"0.01–0.1%","effect":"Acute hemolytic transfusion reaction"},{"rate":"1–5%","effect":"Febrile non-hemolytic transfusion reaction"},{"rate":"1–3%","effect":"Allergic reaction"},{"rate":"0.02–0.1%","effect":"Transfusion-related acute lung injury (TRALI)"},{"rate":null,"effect":"Iron overload (with chronic transfusion)"},{"rate":"<0.01%","effect":"Infection transmission (rare with modern screening)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Transfused red blood cells contain hemoglobin that binds and transports oxygen throughout the body, restoring tissue oxygenation in patients with severe anemia, acute blood loss, or chronic conditions causing erythrocyte deficiency. This is a cellular replacement therapy rather than a pharmacological intervention, providing immediate hemodynamic support and oxygen delivery to vital organs.","oneSentence":"Red blood cell transfusion restores oxygen-carrying capacity by increasing circulating hemoglobin and red blood cell count in anemic or hemorrhaging patients.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:04:29.222Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute hemorrhage and hemodynamic instability"},{"name":"Severe symptomatic anemia"},{"name":"Chronic anemia unresponsive to medical management"},{"name":"Perioperative blood loss"}]},"trialDetails":[{"nctId":"NCT04404881","phase":"PHASE2","title":"Bevacizumab In Hereditary Hemorrhagic Telangiectasia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hanny Al-Samkari, MD","startDate":"2020-11-23","conditions":"Hereditary Hemorrhagic Telangiectasia","enrollment":33},{"nctId":"NCT03910452","phase":"EARLY_PHASE1","title":"Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-10-28","conditions":"Chronic Granulomatous Disease","enrollment":4},{"nctId":"NCT03889834","phase":"NA","title":"Biological Parameters Changes After Autologous Blood Transfusion of Red Blood Cells (200 ml) in Healthy Volunteers.","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-01-25","conditions":"The Focus is on the Detection of the Consequences of Autologous Blood Transfusion in Healthy Volunteers","enrollment":30},{"nctId":"NCT03037164","phase":"PHASE3","title":"INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cerus Corporation","startDate":"2017-05-11","conditions":"Anemia","enrollment":692},{"nctId":"NCT06872333","phase":"PHASE2","title":"Allo HSCT for High Risk Hemoglobinopathies","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2024-11-19","conditions":"Graft Failure, Sickle Cell Disease, Hemoglobinopathies","enrollment":62},{"nctId":"NCT06840756","phase":"PHASE4","title":"Effects of Donor-recipient Sex-matched Blood Transfusion on Patient Outcomes","status":"RECRUITING","sponsor":"Michelle Zeller","startDate":"2025-09-11","conditions":"Red Blood Cell Transfusions, Sex Differences, Health Services","enrollment":11082},{"nctId":"NCT07465029","phase":"","title":"A Study of Incidence, Treatment Patterns, and Outcomes in Transfusion-dependent Lower-risk Myelodysplastic Syndromes in Spain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2026-02-02","conditions":"Lower-risk Myelodysplastic Syndromes (TD LR-MDS)","enrollment":1300},{"nctId":"NCT07422480","phase":"PHASE3","title":"A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions","status":"RECRUITING","sponsor":"Takeda","startDate":"2026-04-01","conditions":"Myelodysplastic Syndrome, Anemia","enrollment":300},{"nctId":"NCT04040023","phase":"NA","title":"Patient Blood Management in Cardiac Surgery","status":"COMPLETED","sponsor":"Clinique Pasteur","startDate":"2019-09-10","conditions":"Surgical Blood Loss","enrollment":900},{"nctId":"NCT04084080","phase":"PHASE3","title":"Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2020-02-26","conditions":"Sickle Cell Disease","enrollment":173},{"nctId":"NCT07446647","phase":"PHASE1","title":"Comparative Analysis of Biotinylated, Irradiated and 51-Chromium Radiolabeled Red Blood Cells for Analysis of Recovery and Survival After Autologous Transfusion","status":"NOT_YET_RECRUITING","sponsor":"Jose Cancelas","startDate":"2026-03","conditions":"Healthy Volunteer Red Blood Cell Labeling Study; Not Disease Focused","enrollment":20},{"nctId":"NCT04171635","phase":"","title":"Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2019-12-16","conditions":"MRI Scans","enrollment":55},{"nctId":"NCT06078696","phase":"PHASE1, PHASE2","title":"Siplizumab for Sickle Cell Disease Transplant","status":"TERMINATED","sponsor":"Columbia University","startDate":"2023-09-28","conditions":"Anemia, Sickle Cell","enrollment":1},{"nctId":"NCT07436767","phase":"NA","title":"Safety and Efficacy of KL003 Cell Injection in Severe Sickle Cell Disease","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-03-01","conditions":"Sickle Cell Disease","enrollment":3},{"nctId":"NCT06979492","phase":"PHASE4","title":"Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease","status":"RECRUITING","sponsor":"Emory University","startDate":"2026-04","conditions":"Sickle Cell Disease, Pregnancy Related","enrollment":50},{"nctId":"NCT07341139","phase":"","title":"Blood Storage Related Mortality and Adverse Effects in Trauma Patients","status":"RECRUITING","sponsor":"Kocaeli City Hospital","startDate":"2026-01-17","conditions":"Transfusion Adverse Reaction, Major Trauma, Blood Product Transfusion for All Conditions","enrollment":300},{"nctId":"NCT06710418","phase":"NA","title":"Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-10-15","conditions":"Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma","enrollment":50},{"nctId":"NCT07328191","phase":"NA","title":"Quality of Life-Guided Transfusion in Refractory MDS or AML","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2026-02-09","conditions":"MDS, AML, Adult, Anemia","enrollment":52},{"nctId":"NCT06909487","phase":"","title":"Clinical Characterization of Very and Extremely Preterm Infants Who Received Excess Erythrocyte Transfusions With Respect to HAS 2014 Recommendations","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2025-03-25","conditions":"Very Preterm and Extremely Preterm Birth, Anemia, Erythrocyte Transfusion","enrollment":201},{"nctId":"NCT02741648","phase":"","title":"RBC Irradiation, Anemia and Gut Injury","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2016-07","conditions":"Anemia, Necrotizing Enterocolitis","enrollment":324},{"nctId":"NCT04419649","phase":"PHASE2","title":"A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)","status":"RECRUITING","sponsor":"Takeda","startDate":"2020-08-19","conditions":"Myelodysplastic Syndromes, Cytopenia","enrollment":160},{"nctId":"NCT05612919","phase":"NA","title":"Red Blood Cells From Umbilical Cord for Transfusion of Preterm Infants","status":"COMPLETED","sponsor":"Hospital Clinic of Barcelona","startDate":"2023-09-13","conditions":"Infant, Extremely Premature, Erythrocyte Transfusion, Umbilical Cord Issue","enrollment":41},{"nctId":"NCT04431999","phase":"PHASE3","title":"Evaluation of a Transfusion Therapy Using Whole Blood in the Management of Coagulopathy in Patients With Acute Traumatic Hemorrhage","status":"COMPLETED","sponsor":"Direction Centrale du Service de Santé des Armées","startDate":"2021-12-04","conditions":"Trauma, Acute Hemorrhage, Coagulopathy","enrollment":200},{"nctId":"NCT04294641","phase":"PHASE2","title":"Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2021-05-10","conditions":"Chronic GVHD","enrollment":10},{"nctId":"NCT06944067","phase":"","title":"Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease","status":"RECRUITING","sponsor":"National Human Genome Research Institute (NHGRI)","startDate":"2025-06-24","conditions":"Sickle Cell Disease","enrollment":50},{"nctId":"NCT04591574","phase":"NA","title":"ABC - A Post Intensive Care Anaemia Management Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Edinburgh","startDate":"2020-09-01","conditions":"Anemia Acute, Fatigue, Physical Disability","enrollment":346},{"nctId":"NCT06743113","phase":"NA","title":"Hypoxic Red Blood Cells in Sickle Cell Anemia","status":"NOT_YET_RECRUITING","sponsor":"Hemanext","startDate":"2026-03","conditions":"Sickle Cell Anaemia, Sickle Cell Anemia Crisis, Sickle Cell Anemia in Children","enrollment":48},{"nctId":"NCT06685848","phase":"NA","title":"Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion","status":"RECRUITING","sponsor":"Hemanext","startDate":"2024-11-29","conditions":"Hematologic Neoplasms","enrollment":24},{"nctId":"NCT04143724","phase":"PHASE2","title":"Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia","status":"RECRUITING","sponsor":"Celgene","startDate":"2019-11-07","conditions":"Beta-Thalassemia","enrollment":99},{"nctId":"NCT07092683","phase":"","title":"Mediation Analysis in Cardiac Surgery","status":"COMPLETED","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-01-01","conditions":"Anemia, Cardiac Surgery, Transfusion","enrollment":13683},{"nctId":"NCT05470816","phase":"PHASE3","title":"Tranexamic Acid to Reduce Delirium After Gastrointestinal Surgery: the TRIGS-D Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bayside Health","startDate":"2022-11-01","conditions":"Surgical Site Infection, Dementia, Cognition","enrollment":826},{"nctId":"NCT06060639","phase":"NA","title":"Variation of Echocardiographic Parameters After Red Blood Cell Transfusion in Emergency Department Anemic Patients","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2023-11-09","conditions":"Anemia, Age Problem, Ultrasonography","enrollment":116},{"nctId":"NCT02352181","phase":"NA","title":"Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment.","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2014-12","conditions":"Liver Transplantation","enrollment":82},{"nctId":"NCT07055503","phase":"","title":"Use of the Hemanext One® Hypoxic Red Blood Cell Storage System for Transfusion in Thalassemia Patients","status":"ENROLLING_BY_INVITATION","sponsor":"University Research Institute for the Study of Genetic & Malignant Disorders in Childhood","startDate":"2025-11-20","conditions":"Transfusion-dependent Beta-Thalassemia, Blood Transfusion","enrollment":30},{"nctId":"NCT07287371","phase":"PHASE4","title":"Sucrosomial Vs Intravenous Iron for Preoperative Anemia","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2025-12-31","conditions":"Anemia, Iron Deficiency Anemia","enrollment":75},{"nctId":"NCT04987489","phase":"PHASE2","title":"A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease","status":"COMPLETED","sponsor":"Forma Therapeutics, Inc.","startDate":"2022-03-28","conditions":"Sickle Cell Disease, Thalassemia","enrollment":53},{"nctId":"NCT02750150","phase":"PHASE3","title":"Freeze-dried Plasma in the Initial Management of Coagulopathy in Trauma Patients","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2013-07-09","conditions":"Trauma, Coagulopathy","enrollment":42},{"nctId":"NCT07121140","phase":"NA","title":"Home Blood Transfusions","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2025-06-03","conditions":"Hematologic Malignancy, Myelodysplastic Syndromes, Acute Myeloid Leukemia","enrollment":30},{"nctId":"NCT04137692","phase":"NA","title":"Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome","status":"SUSPENDED","sponsor":"Weill Medical College of Cornell University","startDate":"2027-09","conditions":"Glucose Transporter Type 1 Deficiency Syndrome, GLUT1DS1","enrollment":12},{"nctId":"NCT06285604","phase":"","title":"Effect Evaluation of Different Blood Products Infusion on Neonatal Anemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Women's Hospital School Of Medicine Zhejiang University","startDate":"2024-09-10","conditions":"Neonatal Anemia","enrollment":200},{"nctId":"NCT06298643","phase":"","title":"Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2023-12-22","conditions":"Lower-risk Myelodysplastic Syndromes","enrollment":177},{"nctId":"NCT05466201","phase":"PHASE2, PHASE3","title":"The Use of Eltrombopag Post HSCT in BMFD","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2022-10-22","conditions":"Stem Cell Transplant Complications","enrollment":118},{"nctId":"NCT03999229","phase":"PHASE1","title":"S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion","status":"RECRUITING","sponsor":"James Reynolds","startDate":"2019-07-25","conditions":"Transfusion Related Complication","enrollment":35},{"nctId":"NCT02570542","phase":"PHASE2","title":"Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2015-10","conditions":"Diffuse Large B-cell Lymphoma (DLBCL), Relapsed Diffuse Large B-cell Lymphoma (DLBCL), Refractory Diffuse Large B-cell Lymphoma (DLBCL)","enrollment":59},{"nctId":"NCT05213806","phase":"NA","title":"WithHolding Enteral Feeds Around Blood Transfusion (International)","status":"RECRUITING","sponsor":"IWK Health Centre","startDate":"2022-01-28","conditions":"Necrotizing Enterocolitis","enrollment":4333},{"nctId":"NCT04879485","phase":"NA","title":"Prehospital Transfusion Strategy in Bleeding Patients","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2021-05-03","conditions":"Hemorrhage, Blood Component Transfusion","enrollment":120},{"nctId":"NCT06824753","phase":"NA","title":"Postoperative Use Of Pump Blood İn Cardiopulmonary Bypass Surgery","status":"COMPLETED","sponsor":"Ataturk University","startDate":"2023-04-01","conditions":"Cardio-pulmonary Bypass","enrollment":60},{"nctId":"NCT01702805","phase":"NA","title":"Transfusion of Prematures Trial","status":"COMPLETED","sponsor":"NICHD Neonatal Research Network","startDate":"2012-12","conditions":"Infant, Newborn, Diseases, Infant, Extremely Low Birth Weight, Infant, Small for Gestational Age","enrollment":1824},{"nctId":"NCT06045689","phase":"PHASE3","title":"A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2023-10-05","conditions":"Myelodysplastic Syndromes","enrollment":106},{"nctId":"NCT05405426","phase":"NA","title":"Trial of Indication-Based Transfusion of Red Blood Cells in ECMO","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2023-04-14","conditions":"Extracorporeal Membrane Oxygenation, Red Blood Cell Transfusion, Organ Failure, Multiple","enrollment":228},{"nctId":"NCT05891249","phase":"PHASE4","title":"A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2023-06-05","conditions":"Anemia","enrollment":85},{"nctId":"NCT07111598","phase":"NA","title":"Immunological Effects of Iron Supplementation in HHT Disease","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2025-09-24","conditions":"Hereditary Haemorrhagic Telangiectasia","enrollment":155},{"nctId":"NCT07191678","phase":"","title":"Mechanisms Affecting the Gut of Preterm Infants Receiving Blood Transfusion With Different Enteral Feed Interventions","status":"NOT_YET_RECRUITING","sponsor":"Imperial College Healthcare NHS Trust","startDate":"2025-11-03","conditions":"NEC - Necrotizing Enterocolitis, NEC, Preterm Babies","enrollment":270},{"nctId":"NCT02963883","phase":"NA","title":"Erythrocyte Transfusion Based on the Measurement of Central Venous Oxygen Saturation in Postoperative Cardiac Surgery","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2016-12","conditions":"Cardiac Surgery","enrollment":160},{"nctId":"NCT03459287","phase":"PHASE3","title":"Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients","status":"COMPLETED","sponsor":"Cerus Corporation","startDate":"2018-12-05","conditions":"Anemia","enrollment":581},{"nctId":"NCT07155031","phase":"PHASE2","title":"Biotin-Acridine Red Cell Exchange Kinetics","status":"NOT_YET_RECRUITING","sponsor":"Cerus Corporation","startDate":"2025-10-15","conditions":"Sickle Cell Disease","enrollment":5},{"nctId":"NCT07152379","phase":"PHASE2","title":"Challenge Transfusion of INTERCEPT Pathogen Reduced Red Blood Cells (RBCs) in Subjects With or Without Pre-existing Antibodies to INTERCEPT RBCs","status":"NOT_YET_RECRUITING","sponsor":"Cerus Corporation","startDate":"2026-01-01","conditions":"Transfusion Reaction, Hemolytic","enrollment":10},{"nctId":"NCT05638581","phase":"PHASE3","title":"Trauma Resuscitation With Low-Titer Group O Whole Blood or Products","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2023-07-27","conditions":"Wounds and Injuries, Shock, Hemorrhagic","enrollment":1100},{"nctId":"NCT07129031","phase":"PHASE3","title":"Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic Shock","status":"NOT_YET_RECRUITING","sponsor":"Xijing Hospital","startDate":"2025-09-01","conditions":"Hemorrhage, Hemorrhagic Shock, Upper Gastrointestinal Bleeding (UGIB)","enrollment":180},{"nctId":"NCT07125612","phase":"","title":"Impact of Perioperative Allogeneic Red Blood Cell Transfusion on Postoperative Myocardial Injury After Liver Resection","status":"COMPLETED","sponsor":"Hao Li","startDate":"2016-01-01","conditions":"Myocardial Injury, Acuter Kidney Injury","enrollment":487},{"nctId":"NCT07123948","phase":"","title":"The Correlation Between Red Cell Transfusion and Complications of Prematurity","status":"NOT_YET_RECRUITING","sponsor":"Clinical Hospital Center Rijeka","startDate":"2025-09-01","conditions":"Retinopathy of Prematurity (ROP), Bronchopulmonary Dysplasia (BPD), Enterocolitis, Necrotizing","enrollment":128},{"nctId":"NCT05835882","phase":"NA","title":"Blood Salvage From Liver Donors: a Feasibility Pilot Study","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2023-06-01","conditions":"Liver Transplantation, Erythrocyte Transfusion","enrollment":10},{"nctId":"NCT05567458","phase":"PHASE2","title":"A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2022-10-17","conditions":"Beta-thalassemia","enrollment":94},{"nctId":"NCT03369210","phase":"PHASE3","title":"Liberal Transfusion Strategy in Elderly Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johann Wolfgang Goethe University Hospital","startDate":"2017-12-04","conditions":"Transfusion-dependent Anemia, Surgery, Anemia","enrollment":2470},{"nctId":"NCT07108374","phase":"NA","title":"Implementation of Red Blood Cell Transfusion Recommendations in the Pediatric Intensive Care Unit","status":"ENROLLING_BY_INVITATION","sponsor":"Stanford University","startDate":"2024-11-30","conditions":"Red Blood Cell Transfusions","enrollment":200},{"nctId":"NCT06809010","phase":"NA","title":"grouP O wholE blooD : storagE leSion impacT And infLammation","status":"RECRUITING","sponsor":"Etablissement Français du Sang","startDate":"2025-03-12","conditions":"Blood Donation, Blood Platelets, Blood Donors","enrollment":30},{"nctId":"NCT06718439","phase":"NA","title":"Hemoglobin Levels for Blood Transfusions During and After Surgery","status":"RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2025-04-16","conditions":"Blood Transfusion, Surgery","enrollment":384},{"nctId":"NCT06102590","phase":"NA","title":"Oxygen Extraction-guided Transfusion","status":"RECRUITING","sponsor":"Università degli Studi di Ferrara","startDate":"2023-11-04","conditions":"Blood Transfusion","enrollment":324},{"nctId":"NCT07094295","phase":"","title":"Perioperative Blood Transfusion and Increased One-year Mortality","status":"COMPLETED","sponsor":"Changhai Hospital","startDate":"2012-01-01","conditions":"Mortality, Perioperative Blood Transfusion, Propensity Score, Retrospective Study, Surgery","enrollment":97443},{"nctId":"NCT05549232","phase":"","title":"Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital","status":"COMPLETED","sponsor":"Hemanext","startDate":"2022-08-24","conditions":"Hematologic Neoplasms, Burns","enrollment":22},{"nctId":"NCT04717414","phase":"PHASE3","title":"An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions","status":"ACTIVE_NOT_RECRUITING","sponsor":"Celgene","startDate":"2021-02-25","conditions":"Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis","enrollment":313},{"nctId":"NCT06425614","phase":"NA","title":"COmbined pLaTelet and eRythrocyte AutotransfusioN During Cardiac surgEry (COLTRANE) Trial","status":"RECRUITING","sponsor":"University Hospital, Bordeaux","startDate":"2024-07-15","conditions":"On-pump Cardiac Surgery, High Risk for Bleeding, Autotransfusion","enrollment":570},{"nctId":"NCT07015684","phase":"PHASE1","title":"131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)","status":"RECRUITING","sponsor":"Columbia University","startDate":"2025-04-28","conditions":"Sickling Disorder Due to Hemoglobin S","enrollment":24},{"nctId":"NCT05841706","phase":"EARLY_PHASE1","title":"Red Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy for Pancreatic Cancer","status":"TERMINATED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2023-08-10","conditions":"Resectable Pancreatic Carcinoma","enrollment":1},{"nctId":"NCT04426591","phase":"PHASE1","title":"Red Blood Cell Survival in Sickle Cell Disease","status":"COMPLETED","sponsor":"Marianne Yee","startDate":"2021-10-29","conditions":"Sickle Cell Disease","enrollment":22},{"nctId":"NCT06276140","phase":"","title":"Iron-deficiency Anaemia and Its Impact on Recovery After Colorectal Cancer Surgery","status":"ENROLLING_BY_INVITATION","sponsor":"Oncology Institute of Vojvodina","startDate":"2024-06-03","conditions":"Iron Deficiencies, Iron Deficiency Anaemia, Postoperative Complications","enrollment":200},{"nctId":"NCT04028700","phase":"PHASE2","title":"The Impact of Oxidative Stress on Erythrocyte Biology","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-01-02","conditions":"Sickle Cell Disease Without Crisis","enrollment":8},{"nctId":"NCT05814094","phase":"NA","title":"Red Blood Cell Transfusion in ECMO - A Feasibility Trial","status":"RECRUITING","sponsor":"Australian and New Zealand Intensive Care Research Centre","startDate":"2023-09-20","conditions":"Blood Loss Anemia, Extracorporeal Membrane Oxygenation Complication, Disability Physical","enrollment":120},{"nctId":"NCT06952361","phase":"","title":"Evaluation of Alternative Transfusion Triggers in Hemodynamically Stable, Non-Ventilated Cancer Patients","status":"COMPLETED","sponsor":"Ardak Arynov","startDate":"2019-03-08","conditions":"Anemia, Blood Transfusion, Cancer","enrollment":107},{"nctId":"NCT05582902","phase":"","title":"Study Investigating Patient-Reported Outcomes in Lower-risk MDS Patients","status":"RECRUITING","sponsor":"University of Leipzig","startDate":"2022-10-11","conditions":"MDS, MDS/MPN","enrollment":60},{"nctId":"NCT04201704","phase":"NA","title":"Effect of Giving Reduced Fluid in Children After Trauma","status":"RECRUITING","sponsor":"Columbia University","startDate":"2018-08-27","conditions":"Critical Illness, Pediatrics, General Surgery","enrollment":250},{"nctId":"NCT04156893","phase":"PHASE1, PHASE2","title":"RH Genotype Matched RBC Transfusions","status":"RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2020-01-30","conditions":"Sickle Cells Disease","enrollment":35},{"nctId":"NCT04156906","phase":"EARLY_PHASE1","title":"RHD Genotype Matched Red Cells for Anti-D","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2020-07-08","conditions":"Sickle Cell Disease, Anti-D Antibodies","enrollment":5},{"nctId":"NCT06462027","phase":"PHASE1","title":"Packed Red Blood Cell Transfusion During Cardiac Arrest","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2025-03-25","conditions":"Cardiac Arrest","enrollment":30},{"nctId":"NCT06947044","phase":"NA","title":"Biomarkers in Patients With Anemia-Induced Thrombocytopenic Bleeding","status":"RECRUITING","sponsor":"Donald Arnold","startDate":"2025-04-11","conditions":"Acute Leukemia, Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukaemia","enrollment":60},{"nctId":"NCT06553833","phase":"","title":"Outcomes of Patient Blood Management in Patients Undergoing Major Surgery","status":"COMPLETED","sponsor":"Helios Klinik Gotha/Ohrdruf","startDate":"2024-09-01","conditions":"Major Surgery","enrollment":25979},{"nctId":"NCT01328262","phase":"NA","title":"A Randomized Clinical Trial on Hemoglobin Dose and Patient Matching","status":"TERMINATED","sponsor":"Haukeland University Hospital","startDate":"2010-11","conditions":"Anemia","enrollment":12},{"nctId":"NCT06012760","phase":"NA","title":"The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-01-04","conditions":"Anemia, Iron Deficiency Anemia, Perioperative","enrollment":400},{"nctId":"NCT03994783","phase":"PHASE3","title":"Transplant Antibody-Mediated Rejection: Guiding Effective Treatments","status":"TERMINATED","sponsor":"Imperial College London","startDate":"2019-07-17","conditions":"Kidney Transplant Rejection, Antibody-mediated Rejection","enrollment":3},{"nctId":"NCT06560164","phase":"NA","title":"Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2024-11-26","conditions":"Transfusion, Red Blood Cell, Extracorporeal Membrane Oxygenation","enrollment":526},{"nctId":"NCT04920045","phase":"NA","title":"A Trial to Assess the Effect of Transfusion Strategies on Fatigability Levels After Hospital Discharge","status":"TERMINATED","sponsor":"University of Chicago","startDate":"2022-02-01","conditions":"Anemia, Red Blood Cell Transfusion, Fatigability","enrollment":23},{"nctId":"NCT02926274","phase":"","title":"Transfusion Using Stored Whole Blood","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2017-10-18","conditions":"Trauma, Hemorrhage, Coagulopathy","enrollment":330},{"nctId":"NCT06889272","phase":"","title":"Investigation of the Relationship Between Blood Transfusion Volume and Development of Renal Failure in Pediatric Patients Undergoing Cardiovascular Surgery","status":"COMPLETED","sponsor":"Hacettepe University","startDate":"2024-01-31","conditions":"Congenital Cardiac Defect, Acute Renal Injury, Blood Transfusion Complication","enrollment":205},{"nctId":"NCT06495294","phase":"NA","title":"SWiFT Canada (Study of Whole Blood in Frontline Trauma)","status":"RECRUITING","sponsor":"Unity Health Toronto","startDate":"2024-12-16","conditions":"Trauma","enrollment":60},{"nctId":"NCT06851390","phase":"","title":"Inflammation and Cerebral Oxygenation in Preterm Newborns Following Fetal Red Blood Cell Transfusion Compared to Adult Red Blood Cell Transfusion","status":"COMPLETED","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2024-05-14","conditions":"Preterm Newborns","enrollment":75},{"nctId":"NCT02338947","phase":"NA","title":"Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2019-01-01","conditions":"Frail Elderly, Coronary Artery Disease","enrollment":440},{"nctId":"NCT06857812","phase":"","title":"Significance of Ultrasound Combined with Near-Infrared Spectroscopy in Monitoring Transfusion-Associated Intestinal Injury in Extremely Preterm Infants: a Study Protocol for a Prospective, Observational Study","status":"NOT_YET_RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2025-02-24","conditions":"Transfusion-Associated Intestinal Injury，Ultrasound，Near-Infrared Spectroscopy","enrollment":100},{"nctId":"NCT02179359","phase":"NA","title":"Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2014-09-02","conditions":"Sickle Cell Disease, Transfusion Dependent Alpha- or Beta- Thalassemia, Diamond Blackfan Anemia","enrollment":38},{"nctId":"NCT05634109","phase":"PHASE3","title":"Whole Blood in Trauma Patients With Hemorrhagic Shock","status":"RECRUITING","sponsor":"Fundacion Clinica Valle del Lili","startDate":"2023-01-14","conditions":"Trauma, Trauma Injury, Trauma, Multiple","enrollment":220},{"nctId":"NCT05100212","phase":"PHASE2","title":"umBilical Or Adult Donor Red Blood Cells in Extremely Low Gestational Age Neonates and Retinopathy of Prematurity (BORN)","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-12-01","conditions":"Retinopathy of Prematurity","enrollment":146}],"_emaApprovals":[],"_faersSignals":[{"count":6,"reaction":"PLATELET COUNT DECREASED"},{"count":5,"reaction":"FEBRILE NEUTROPENIA"},{"count":4,"reaction":"PNEUMONIA"},{"count":4,"reaction":"SICKLE CELL ANAEMIA WITH CRISIS"},{"count":4,"reaction":"THROMBOCYTOPENIA"},{"count":3,"reaction":"ANAEMIA"},{"count":3,"reaction":"ATRIAL FIBRILLATION"},{"count":3,"reaction":"MYELODYSPLASTIC SYNDROME"},{"count":3,"reaction":"OEDEMA PERIPHERAL"},{"count":3,"reaction":"OFF LABEL USE"}],"_approvalHistory":[],"publicationCount":3881,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["erythrocyte transfusion","PRBC transfusion","RBC transfusion","• Red blood cells","• Transfusion"],"phase":"marketed","status":"active","brandName":"Red Blood Cell Transfusion","genericName":"Red Blood Cell Transfusion","companyName":"Rutgers, The State University of New Jersey","companyId":"rutgers-the-state-university-of-new-jersey","modality":"Biologic","firstApprovalDate":"","aiSummary":"Red blood cell transfusion restores oxygen-carrying capacity by increasing circulating hemoglobin and red blood cell count in anemic or hemorrhaging patients. Used for Acute hemorrhage and hemodynamic instability, Severe symptomatic anemia, Chronic anemia unresponsive to medical management.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}